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Nurse-led management of chronic 
diseases
This study of 38 public sector primary care clinics in the Western 
Cape Province, South Africa (SA), suggests that training nurses 
in the use of a management tool involving an expanded role in 
managing non-communicable diseases (NCDs) is safe and feasible, 
but did not result in treatment intensification or improved case 
detection for index diseases. However, the intervention, with some 
adjustment, has been adopted for implementation in primary care 
clinics throughout SA. Primary Care 101 (PC101) is a programme 
designed to support and expand nurses’ role in NCD care, and is 
made up of educational outreach and a clinical management tool 
with enhanced prescribing provisions. Nurses in the intervention 
clinics were trained to use the PC101 management tool during 
educational outreach sessions delivered by health department 
trainers and were authorised to prescribe an expanded range of drugs 
for several NCDs. Control clinics continued use of the Practical 
Approach to Lung Health and HIV/AIDS in South Africa (PALSA 
PLUS) management tool and usual training. Patients attending 
these clinics with one or more of hypertension (n=3 227), diabetes 
(n=1 842) or chronic respiratory disease (n=1 157) or who screened 
positive for depression (n=2  466), totalling 4  393  patients, were 
enrolled between 28 March 2011 and 10 November 2011. Primary 
outcomes were treatment intensification in the hypertension, 
diabetes, and chronic respiratory disease cohorts, defined as the 
proportion of patients in whom treatment was escalated during 
follow-up over 14 months, and case detection in the depression 
cohort. However, treatment intensification rates in the intervention 
clinics were no better than those in the control clinics.
Fairall LR, Folb N, Timmerman V, et al. Educational outreach with an integrated clinical tool for nurse-
led non-communicable chronic disease management in primary care in South Africa: A pragmatic cluster 
randomised controlled trial. PLoS Med 2016. http://dx.doi.org/10.1371/journal.pmed.1002178 (published 22 
November 2016).
Minimally invasive autopsy: 
Identifying the cause of death in 
Mozambique
An observational study that coupled minimally invasive autopsy 
(MIA) and complete diagnostic autopsy (CDA) performed in 
112 dead patients in Mozambique suggests that the simple MIA can 
identify the cause of many adult deaths. In many low-income regions, 
current methods used to identify cause of death (verbal autopsy, 
clinical records and complete autopsies) are either inaccurate, not 
feasible or poorly accepted. In this study, the MIA analyses were 
done blindly, with no knowledge of the clinical data or the results 
of the CDA, and the MIA diagnosis was compared with the CDA 
diagnosis of cause of death. CDA diagnoses comprised infectious 
diseases (n=80, 71.4%), malignant tumours (n=16, 14.3%), and other 
diseases, including non-infectious cardiovascular, gastrointestinal, 
kidney, and lung diseases (n=16, 14.3%). An MIA diagnosis was 
obtained in 100/112 cases (89.2%). The overall concordance between 
the MIA diagnosis and CDA diagnosis was 75.9% (85/112). The 
concordance was higher for infectious diseases and malignant 
tumours (63/80 (78.8%) and 13/16 (81.3%), respectively) than for 
other diseases (9/16, 56.2%). The specific micro-organisms causing 
death were identified in the MIA in 62/74 (83.8%) of the infectious 
disease deaths with a recognised cause. This tool could have a major 
role in improving the understanding and surveillance of causes 
of death in areas where infectious diseases are a common cause of 
mortality.
Castillo P, Martinez MJ, Ussene E, et al. Validity of a minimally invasive autopsy for cause of death 
determination in adults in Mozambique: An observational study. PLoS Med 2016. http://dx.doi.org/10.1371/
journal.pmed.1002171 (published 22 November 2016).
Diet, lifestyle, body mass index and 
mortality
In this longitudinal study, with up to 32 years of follow-up of 74 582 
women from the Nurses’ Health Study and 39  284 men from the 
Health Professionals Follow-up Study, the conclusions were that 
although people with a high BMI can have lower risk of premature 
mortality if they also have at least one low risk lifestyle factor, 
the lowest risk of premature mortality is those with a BMI in the 
range 18.5 - 22.4, with high scores on healthy eating and physical 
activity, moderate alcohol intake and who do not smoke. During the 
32 years of follow-up there were more deaths from cancer (n=10 808) 
than from cardiovascular disease (n=189) – interesting in itself. A 
combination of at least three low-risk lifestyle factors, along with the 
range of BMI mentioned, was associated with the lowest risk of all 
cause and cardiovascular mortality. The greatest risk was found in 
those with a BMI in the range 22.5 - 24.9 with none of the four low 
risk lifestyle factors.
Veronese N, Li Y, Monson JE, et al. Combined associations of body weight and lifestyle factors with all 
cause and cause specific mortality in men and women: Prospective cohort study. BMJ 2016;355:i5855. http://
dx.doi.org/10.1136/bmj.i5855 (published 24 November 2016).
Methylprednisone injected through 
the eardrum effective in combating 
Ménière’s symptoms
A recent study published in The Lancet shows that injections of the 
steroid methylprednisone through the eardrum are as effective as 
current standard treatment of gentamicin in reducing the dizziness 
associated with Ménière’s disease, but without the associated risk of 
hearing loss. This current treatment relies on the ototoxic effect of 
the antibiotic, and around 20% of patients are left with permanent 
hearing loss. In this double-blind trial, 60 patients with unilateral 
Ménière’s disease were randomly assigned to two intratympanic 
injections of methylprednisone or gentamicin, given 2 weeks apart. 
Patients treated with methylprednisolone showed a 90% reduction 
in the mean number of attacks they experienced, from 16.4 in the 
6 months before treatment to 1.6 at 18 - 24 months after treatment. 
This compared with an 87% reduction in attacks with gentamicin, 
from a mean of 19.9 to 2.5.
Patel M, Agarwal K, Arshad Q, et al. Intratympanic methylprednisolone versus gentamicin in patients 
with unilateral Ménière’s disease: A randomised, double-blind, comparative effectiveness trial. Lancet 
2016;388(10061):2753-2762. http://dx.doi.org/10.1016/S0140-6736(16)31461-1
Prediabetes associated with increased 
risk of cardiovascular and all-cause 
mortality
A meta-analysis of 53 prospective cohort studies with 1 611 339 
indi viduals suggests that prediabetes is associated with an increased 
risk of cardiovascular disease. The analysis looked at different 
definitions of prediabetes and for associations between the risk of 
composite cardiovascular disease, coronary heart disease, stroke, 
all-cause mortality and prediabetes. Prediabetes was defined as 
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impaired fasting glucose level according to the criteria of the 
American Diabetes Association (IFG-ADA; fasting glucose 5.6 - 
6.9  mmol/L), the WHO expert group (IFG-WHO; fasting glucose 
6.1 - 6.9 mmol/L), impaired glucose tolerance (2-hour plasma glucose 
concentration 7.8 - 11.0 mmol/L during an oral glucose tolerance 
test), or raised glycated haemoglobin (HbA1c) of 39 - 47 mmol/mol 
(5.7 - 6.4%) according to American Diabetes Association criteria or 
42 - 47 mmol/mol (6.0 - 6.4%) according to the National Institute for 
Health and Care Excellence (NICE) guideline. Increases in HBA1c to 
39 - 47 mmol/mol or 42 - 47 mmol/mol were both associated with 
an increased risk of composite cardiovascular disease (1.21 and 1.25, 
respectively) and coronary heart disease (1.15 and 1.28, respectively), 
but not with an increased risk of stroke and all-cause mortality.
Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and 
all cause mortality: Systematic review and meta-analysis. BMJ 2016;355:i5953. http://dx.doi.org/10.1136/bmj.
i5953 (published 23 November 2016).
E-cigarettes raise risk of persistent 
cough and wheeze in teenagers
A questionnaire administered to more than 2 000 teenagers aged 
between 16 and 18 years as part of the Southern California Children’s 
Health Study showed that those who used e-cigarettes had twice the 
risk of respiratory symptoms such as persistent cough, bronchitis 
and wheeze as those who did not. The risk of bronchitis rose with 
frequency of use, from a two-thirds higher risk in teenagers who used 
e-cigarettes for 1 - 2 days in the previous months to two and a half 
times the risk in those using them on ≥3 days, when compared with 
never users. Just under a tenth (9.6%, n=201) of the adolescents who 
responded to the survey were current users of e-cigarettes, having 
used them at least once in the previous 30 days, 14.4% were past users, 
reporting that they had used e-cigarettes previously but not in the past 
month, and 76% said that they had never used e-cigarettes. E-cigarettes 
contain chemicals toxic to the lungs, including oxidant metals, glycerol 
vapour, diketone flavouring compounds and nicotine.
McConnell  R,  Barrington-Trimis  JL,  Wang  K,  et al. Electronic-cigarette use and respiratory symptoms 
in adolescents. Am J Respir Crit Care Med 2016. http://www.atsjournals.org/doi/abs/10.1164/rccm.201604-
0804OC (published online 2 November 2016).
Alcohol consumption and different 
stroke types
Light and moderate alcohol consumption appears to be inversely 
associated with ischaemic stroke, while heavy drinking is asso-
ciated with increased risk of all types of stroke, particularly 
haemorrhagic stroke, according to a meta-analysis conducted 
by Swedish researchers. Additional data from 73 587 Swedish 
adults in two prospective studies were included. Study-specific 
results were combined in a random-effects model. The meta-
analysis included 27 prospective studies with data on ischaemic 
stroke (25 studies), intracerebral haemorrhage (11 studies), and/
or subarachnoid haemorrhage (11 studies). Light and moderate 
alcohol consumption was associated with a lower risk of ischaemic 
stroke, whereas high and heavy drinking was associated with 
an increased risk. Light and moderate alcohol drinking was not 
associated with any haemorrhagic stroke subtype. High alcohol 
consumption (>2 - 4 drinks/day) was associated with a non-signi-
ficant increased risk of both haemorrhagic stroke subtypes, and 
the relative risk for heavy drinking (>4 drinks/day) was 1.67 for 
intracerebral haemorrhage and 1.82 for subarachnoid haemorrhage.
Larsson S, Wallin A, Wolk A, Markus HS. Differing association of alcohol consumption with different stroke 
types: A systematic review and meta-analysis. BMC Med 2016;14:178. http://dx.doi.org/10.1186/s12916-016-
0721-4
Stage at breast cancer diagnosis and 
survival in sub-Saharan Africa
A recent meta-analysis of breast cancer stage at diagnosis in sub-
Saharan Africa suggests that strategies for early diagnosis of breast 
cancer should be regarded as a major priority by cancer control 
programmes in the region. The authors included 83 studies, which 
consisted of 26 788 women from 17 sub-Saharan African countries. 
They found wide between-study heterogeneity in the percentage of 
later-stage disease at diagnosis. The percentage of patients with late-
stage disease at diagnosis did not vary by region in black women, 
but was lower in non-black women from southern Africa than in 
black women in any region (absolute difference from black women 
in western Africa −18.1%,), and higher for populations from mixed 
(urban and rural) settings rather than urban settings (13.2%, 
5.7 - 20.7, in analyses restricted to black women). The percentage 
of patients with late-stage disease at diagnosis in black Africans 
decreased over time (–10.5%, −19.3 - −1.6; for 2000 or later v. 1980 
or before), but it was still higher around 2010 than it was in white 
and black women in the USA 40 years previously. The incidence of 
breast cancer in sub-Saharan Africa is relatively low, but as survival 
from the disease in the region is poor, mortality rates are as high as 
in high-income countries. Stage at diagnosis is a major contributing 
factor to poor survival from breast cancer.
Jedy-Agba E, McCormack V, Adebamowo C, dos-Santos-Silva I. Stage at diagnosis of breast cancer in sub-
Saharan Africa: A systematic review and meta-analysis. Lancet Global Health 2016;4(12):e923-e935. http://
dx.doi.org/10.1016/S2214-109X(16)30259-5
Bridget Farham
Editor
ugqirha@iafrica.com
